SCHEMBL10690190

SCHEMBL10690190

O=C1NC(=O)C(Cc2ccc3c(c2)CC(Cc2ccccc2)CC3)S1

nearest known ligand 0.52

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ PPARG P37231 5/20 0.52
▸ FFAR1 O14842 4/20 0.48
▸ MAPT P10636 2/20 0.48
▸ ALDH1A1 P00352 1/20 0.46
▸ NPSR1 Q6W5P4 1/20 0.46
▸ CA2 P00918 1/20 0.45
▸ MAOB P27338 1/20 0.45
▸ PPARA Q07869 1/20 0.44
▸ PTPN1 P18031 1/20 0.44
▸ CYP19A1 P11511 2/20 0.43
▸ KDM4E B2RXH2 1/20 0.42
▸ LMNA P02545 1/20 0.42
▸ HIF1A Q16665 1/20 0.42
▸ MAOA P21397 1/20 0.42
▸ CISD1 Q9NZ45 1/20 0.42
▸ KMT2A Q03164 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10686431 0.96 PPARG (0.52) PPARGFFAR1MAPTALDH1A1NPSR1
SCHEMBL10683704 0.91 PPARG (0.56) PPARGFFAR1MAPTALDH1A1NPSR1
SCHEMBL10686465 0.89 PPARG (0.50) PPARGFFAR1MAPTALDH1A1NPSR1
SCHEMBL10366648 0.81 PPARG (0.50) PPARGFFAR1MAPTALDH1A1NPSR1
SCHEMBL10691392 0.80 CYP26A1 (0.56) PPARGFFAR1MAPTALDH1A1NPSR1
Englitazone SCHEMBL37697 0.78 PPARG (0.50) PPARGFFAR1MAPTALDH1A1NPSR1
Englitazone SCHEMBL20125579 0.78 PPARG (0.50) PPARGFFAR1MAPTALDH1A1NPSR1
Englitazone SCHEMBL29377687 0.78 PPARG (0.50) PPARGFFAR1MAPTALDH1A1NPSR1
Englitazone SCHEMBL20125577 0.78 PPARG (0.50) PPARGFFAR1MAPTALDH1A1NPSR1
Englitazone SCHEMBL4727851 0.78 PPARG (0.50) PPARGFFAR1MAPTALDH1A1NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4738972-A Hypoglycemic thiazolidinediones PFIZER INC. (US) 1988-04-19 — — US disclosed
Send feedback